The $83bn question: Will orphan drugs get too big for their boots?
This article was originally published in Scrip
Executive Summary
For the past seven years, 28 February has been Rare Disease Day, and the growing public profile of this date mirrors the rising fortunes of orphan drugs, which now account for nearly 15% of the global prescription pharma market.